Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
SYSTEMATIC FINANCIAL MANAGEMENT LP LYTS Lsi Industries Inc 13G/A 6.68% 3mo
SYSTEMATIC FINANCIAL MANAGEMENT LP KVHI Kvh Industries Inc De 13G/A 4.48% 3mo
ARK Investment Management LLC PACB Pacific Biosciences Of California, Inc. 13G/A 9.59% 3mo
BAKER BROS. ADVISORS LP CERS Cerus Corp 13G/A 3.2% 3mo
NOMURA HOLDINGS INC ITGR Integer Holdings Corp 13G 5.4% 3mo
MILLENNIUM MANAGEMENT LLC FAC Factorial Energy Inc. 13G/A 0.5% 3mo
AMERIPRISE FINANCIAL INC BRBR Bellring Brands, Inc. 13G 5% 3mo
METEORA CAPITAL, LLC BHAV BHAV Acquisition Corp 13G/A 0% 3mo
Paradigm Biocapital Advisors LP VRDN Viridian Therapeutics, Inc.\DE 13G/A 6.1% 3mo
MASON CAPITAL MANAGEMENT LLC NVRI Enviri Corp 13G/A 0% 3mo
PERCEPTIVE ADVISORS LLC XFOR X4 Pharmaceuticals, Inc 13G/A 8.1% 3mo
Ryan Israel PS Pershing Square Inc. 13G 7.8% 3mo
Joseph D. Burns AIRO AIRO Group Holdings, Inc. 13G 5.3% 3mo
METEORA CAPITAL, LLC JACS Jackson Acquisition Co II 13G/A 2.22% 3mo
WHITEBOX ADVISORS LLC ELBM Electra Battery Materials Corp 13G/A 9.9% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC OHAC Oceanhawk Acquisition Corp. 13G 7.9% 3mo
Pantera Capital Partners LP DYNC Dynamix Corp 13G/A 0% 3mo
American Century Investment Management, Inc. AMCX AMC Global Media Inc. 13G 5.2% 3mo
FR Capital Holdings, L.P. MRLN Merlin, Inc. 13G/A 12.6% 3mo
AMERIPRISE FINANCIAL INC BW Babcock & Wilcox Enterprises, Inc. 13G 5.1% 3mo
Alyeska Investment Group, L.P. GLOB Globant S.A. 13G 6.74% 3mo
Ikarian Capital, LLC TRAW Traws Pharma, Inc. 13G/A 9.5% 3mo
Fourthstone LLC AVBH Avidbank Holdings, Inc. 13G/A 6.4% 3mo
Aldersgate Capital Partners Ltd. PDC Perpetuals.com Ltd 13G/A 0% 3mo
METEORA CAPITAL, LLC XRPNU Armada Acquisition Corp. II 13G/A 8.37% 3mo
Vivo Opportunity Fund Holdings, L.P. UNCY Unicycive Therapeutics, Inc. 13G/A 9.99% 3mo
MPM BIOIMPACT LLC CLYM Climb Bio, Inc. 13G/A 0% 3mo
Lynx1 Capital Management LP TCRX TScan Therapeutics, Inc. 13G/A 13.1% 3mo
First Trust Capital Management L.P. MACI Melar Acquisition Corp. I 13G/A 2.51% 3mo
COHEN & STEERS, INC. HST Host Hotels & Resorts, Inc. 13G/A 6.56% 3mo
American Century Investment Management, Inc. XPRO Expro Ltd 13G 7.1% 3mo
Balyasny Asset Management L.P. SGMT Sagimet Biosciences Inc. 13G 5.93% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ PNR PENTAIR plc 13G/A 4% 3mo
SUVRETTA CAPITAL MANAGEMENT, LLC FULC Fulcrum Therapeutics, Inc. 13G/A 5.5% 3mo
AWM Investment Company, Inc. MASS 908 Devices Inc. 13G/A 11.8% 3mo
Woodline Partners LP CALC CalciMedica, Inc. 13G 8.1% 3mo
ALLIANCEBERNSTEIN L.P. MANH Manhattan Associates Inc 13G/A 3.9% 3mo
Lightspeed General Partner X, L.P. NAVN Navan, Inc. 13G/A 8.4% 3mo
Fort Baker Capital Management LP CRAN Crane Harbor Acquisition Corp. II 13G 7.2% 3mo
Nantahala Capital Management, LLC CWH Camping World Holdings, Inc. 13G/A 7.16% 3mo
Portolan Capital Management, LLC QTRX Quanterix Corp 13G/A 4.02% 3mo
ALLIANCEBERNSTEIN L.P. ICFI ICF International, Inc. 13G 7.8% 3mo
Sculptor Capital LP SHC Sotera Health Co 13G/A 8.41% 3mo
ARK Investment Management LLC CERS Cerus Corp 13G/A 8.95% 3mo
1607 Capital Partners, LLC PAI Western Asset Investment Grade Income Fund Inc. 13G/A 5.87% 3mo
ARISTEIA CAPITAL, L.L.C. HDRN Hadron Energy, Inc. 13G/A 6.59% 3mo
ARMISTICE CAPITAL, LLC IMNN Imunon, Inc. 13G/A 9.99% 3mo
RA CAPITAL MANAGEMENT, L.P. RNA Atrium Therapeutics, Inc. 13G/A 0% 3mo
AMERIPRISE FINANCIAL INC PSNL Personalis, Inc. 13G/A 5.8% 3mo
FARALLON CAPITAL MANAGEMENT LLC SVRA Savara Inc 13G/A 6.8% 3mo